Strs Ohio Pacira Bio Sciences, Inc. Transaction History

Strs Ohio

$25.5 Billion
Q3 2024

A detailed history of Strs Ohio transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Strs Ohio holds 900 shares of PCRX stock, worth $17,082. This represents 0.0% of its overall portfolio holdings.

Number of Shares

900

Holding current value

$17,082

% of portfolio

0.0%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$11.7 - $28.46 $10,530 - $25,614	900 New	900 $13,000
Q3 2022 Oct 27, 2022	SELL	$51.24 - $58.89 $25,620 - $29,445	-500 Reduced 71.43%	200 $10,000
Q2 2022 Jul 25, 2022	SELL	$51.49 - $81.64 $51,490 - $81,640	-1,000 Reduced 58.82%	700 $40,000
Q1 2022 Apr 21, 2022	BUY	$60.03 - $76.49 $102,051 - $130,032	1,700 New	1,700 $129,000
Q2 2021 Jul 26, 2021	SELL	$59.18 - $69.99 $17,754 - $20,997	-300 Closed	0 $0
Q4 2020 Jan 25, 2021	SELL	$50.47 - $66.26 $100,940 - $132,520	-2,000 Reduced 86.96%	300 $17,000
Q3 2020 Dec 14, 2020	BUY	$51.97 - $63.0 $83,152 - $100,800	1,600 Added 228.57%	2,300 $138,000
Q2 2020 Jul 23, 2020	BUY	$30.8 - $52.47 $21,560 - $36,729	700 New	700 $36,000

Others Institutions Holding PCRX

# of Institutions

263

Shares Held

50.4M

Call Options Held

429K

Put Options Held

391K

Black Rock Inc. New York, NY

8.01M
Shares

$152 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.3M
Shares

$101 Million
0.0% of portfolio
Pacer Advisors, Inc. Malvern, PA

4.96M
Shares

$94.2 Million
0.18% of portfolio
State Street Corp Boston, MA

2.01M
Shares

$38.2 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.98M
Shares

$37.6 Million
0.05% of portfolio

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $870M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account